Regular ArticleTreatment of mature B-ALL and high grade B-NHL in children
References (61)
Non-Hodgkin's lymphoma
European Journal of Cancer
(1998)- et al.
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Societe Francaise d'Oncologie Pediatrique LMB89 protocol
Annals of Oncology
(2002) - et al.
The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia
Blood
(2001) - et al.
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin–Frankfurt–Munster Group Trial NHL-BFM 90
Blood
(1999) - et al.
A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis
Blood
(2001) - et al.
High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: a report from the European Lymphoma Bone Marrow Transplantation Registry
Blood
(1997) - et al.
Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Societe Francaise d'Oncologie Pediatrique
Blood
(1993) - et al.
Molecular biology of Burkitt's lymphoma
Journal of Clinical Oncology
(2000) African Burkitt's lymphoma. History, biology, clinical features, and treatment
American Journal of Pediatric Hematology and Oncology
(1991)- et al.
Non-Hodgkin's lymphoma in childhood
New England Journal of Medicine
(1996)
Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults
Seminars in Oncology
(1980)
B-acute lymphoblastic leukaemia. The European experience
International Journal of Pediatric Hematology/Oncology
(1998)
Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma
Journal of Clinical Oncology
(2001)
Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)
New England Journal of Medicine
(1983)
Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society
Journal of Clinical Oncology
(1986)
Updated results of the LMB86 protocol of the French Society of Pediatric Oncology (SFOP) for B-cell non Hodgkin's lymphoma with CNS involvement and B ALL
Medical and Pediatric Oncology
(1990)
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children
Journal of Clinical Oncology
(1991)
High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma
Journal of Clinical Oncology
(1988)
Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology
Journal of Clinical Oncology
(1990)
[BFM study 1981/83 of the treatment of highly malignant non-Hodgkin's lymphoma in children: results of therapy stratified according to histologic immunological type and clinical stage]
Klinic Padiatrics
(1984)
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage—a report of the Berlin–Frankfurt–Munster Group
Journal of Clinical Oncology
(1995)
A 4h infusion of methotrexate 5 g/sqm is not as efficacious for treatment of advanced B-cell neoplasms of chidhood and adolescence than a 24h IV infusion although less toxic. Interim results of trial NHL-BFM 95
Blood
(2001)
Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol
British Journal of Cancer
(2000)
Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)—results of the UKCCSG 9003 protocol
British Journal of Cancer
(1998)
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group
Medical and Pediatric Oncology
(1997)
Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study
Journal of Clinical Oncology
(1996)
Successful treatment of small noncleaved cell lymphoma and B cell ALL with CNS involvement: a Pediatric Oncology Group (POG) study
Journal of Clinical Oncology
(2000)
The addition of VP-Ifosfamide did not improve EFS for CNS negative patients with advanced-stage small noncleaved lymphoma or B-cell ALL: a POG study
Journal of Clinical Oncology
(2001)
B-cell acute lymphoblastic leukemia (B-ALL): a report of 17 pediatric cases
Haematologica
(1992)
Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate (‘Orange’) in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report
Leukemia
(2002)
Cited by (25)
Involvement of thyroid gland at non hodgkin lymphoma initial diagnosis: 2 Pediatric cases
2006, Archives de PediatriePerspectives of the management of childhood lymphoma: Experience at Tygerberg Hospital, Western Cape, South Africa
2005, Transfusion and Apheresis ScienceGender and age-related differences in Burkitt lymphoma - Epidemiological and clinical data from the Netherlands
2004, European Journal of CancerRisk factors for relapse in childhood acute lymphoblastic leukemia: Prediction and prevention
2015, Expert Review of Hematology
- f1
*Tel: +33-1-42-11-41-76; Fax: +33-1-42-11-52-75; E-mail: [email protected] (C. Patte).
Copyright © 2002 Elsevier Science Ltd. All rights reserved.